I have cold agglutinin disease (CAD), a rare form of autoimmune hemolytic anemia, which is an often misunderstood disease. When people hear about anemia, they immediately think you need iron and want ...

Sanofi and Recordati expect to complete the transaction by the end of this year. Enjaymo treats cold agglutinin disease, a condition in which the immune system attacks red blood cells and causes ...

Cold autoimmune hemolytic anemia (c-AIHA), or cold agglutinin disease (CAD), most commonly affects adults between 40 and 80 years old. With CAD, antibodies activate at cooler temperatures and ...

Cold agglutinin disease is a condition that causes low red blood cell (RBC) counts. Symptoms can include fatigue, weakness, or shortness of breath. Cold agglutinin disease is a type of autoimmune ...

Cold agglutinin disease (CAD) is a condition that makes your body’s immune system attack your red blood cells and destroy them. It’s triggered by cold temperatures, and it can cause problems ...

What are the symptoms for cold agglutinin disease, and how is it diagnosed? -- P.W. ANSWER: Cold agglutinin disease is a specific type of anemia where antibodies attack and destroy a person’s ...

Learn more. DEAR DR. ROACH: What are the symptoms for cold agglutinin disease, and how is it diagnosed? — P.W. ANSWER: Cold agglutinin disease is a specific type of anemia where antibodies ...

Muscle and joint pain may overlap, but they can have different causes and treatment approaches. Muscle and joint pain can accompany swelling, stiffness, reduced mobility, and other symptoms. This ...

Cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia — a condition in which you have inadequate red blood cells due to premature destruction of those cells by your own ...

3. The business will be boosted Diversity and inclusion are important factors that many people look for when accepting a job offer. Those that see that your business has people from all ...

Patients with the rare blood disorder cold agglutinin disease (CAD), now have a drug that will help limit the blood transfusions they need. On Friday, the FDA approved Sanofi’s Enjaymo ...